Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in TAP vs Caudal Block for Pediatric Hernia
NCT04926454Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoints: Postoperative analgesic requirements at 24 hours and Analgesic effect at 24 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04926454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04926454.